These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28717548)

  • 21. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between ciprofloxacin and trimethoprim-sulfamethoxazole in antibiotic prophylaxis for transrectal prostate biopsy.
    Atılgan D; Gençten Y; Kölükçü E; Kılıç Ş; Uluocak N; Parlaktaş BS; Erdemir F
    Turk J Urol; 2015 Mar; 41(1):27-31. PubMed ID: 26328195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy.
    Farrell JJ; Hicks JL; Wallace SE; Seftel AD
    Res Rep Urol; 2017; 9():37-41. PubMed ID: 28280717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal culture-directed antibiotic prophylaxis before transrectal prostate biopsy: Reduced infectious complications and healthcare costs.
    Baldissera-Aradas JV; Rodríguez-Villamil L; Blanco-Fernández R; Pérez-García C; Viejo de la Guerra G; González-Rodríguez I; Mosquera-Madera J
    Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):465-472. PubMed ID: 29331324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: A prospective randomized study.
    Fahmy A; Rhashad H; Mohi M; Elabbadie A; Kotb A
    Prostate Int; 2016 Sep; 4(3):113-7. PubMed ID: 27689069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin-Resistant Bacteria on Pre-Prostate Biopsy Rectal Swab Culture: A Northwest Ohio Study.
    Buck B; Fumo D; Arora K; Jain S; Sindhwani P
    Surg Infect (Larchmt); 2018; 19(6):614-617. PubMed ID: 30129906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective transperineal prostate biopsy for fluoroquinolone-resistance patients reduces sepsis and cost.
    Al-Mitwalli A; Kyriazis G; El-Taji O; Chandra E; Deborah W; Burns P; Fady Y; Simms M; Nicholas S
    Curr Urol; 2021 Jun; 15(2):115-118. PubMed ID: 34168531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.
    Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW
    World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Value of Rectal Cultures in Treatment of Sepsis Following Post-Transrectal Ultrasound-Guided Prostate Biopsy.
    Gottesman T; Yossepowich O; Harari-Schwartz O; Tsivian A; Idler J; Dan M
    Urol Int; 2015; 95(2):177-82. PubMed ID: 25871322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.
    Batura D; Rao GG; Nielsen PB
    BJU Int; 2010 Oct; 106(7):1017-20. PubMed ID: 20346055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.
    Duplessis CA; Bavaro M; Simons MP; Marguet C; Santomauro M; Auge B; Collard DA; Fierer J; Lesperance J
    Urology; 2012 Mar; 79(3):556-61. PubMed ID: 22386395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy.
    Li CK; Tong BCY; You JHS
    Int J Infect Dis; 2016 Feb; 43():7-12. PubMed ID: 26686941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of drug susceptibility between Escherichia coli detected in stool cultures of patients undergoing transrectal prostate needle biopsy and Escherichia coli in hospital-wide urine antibiograms.
    Etani T; Mogami T; Yamaguchi S; Takeda T; Sugino T; Shimizu N; Noda Y; Nagai T; Nozaki S; Iida K; Naiki T; Ando R; Kawai N; Yasui T
    J Infect Chemother; 2022 Feb; 28(2):343-346. PubMed ID: 34750049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.